Latest Updates

23rd Feb 2022
NEW YORK, NY, WEDNESDAY, FEBRUARY 23, 2022 – Last Friday, ExxonMobil released a 2020 Lobbying Report detailing its lobbying oversight, philosophy, positions, and details on its lobbying activities and expenditures. The report is in...
Read more
9th Feb 2022
High-road jobs, stakeholder consultation, and a focus on racial and economic justice are featured as central to a just and equitable transition to a clean energy economy.    NEW YORK, NY, WEDNESDAY...
Read more
25th Jan 2022
NEW YORK, NY, TUESDAY, JANUARY 25TH, 2022 - As the economy begins to emerge from the deepest impacts of the pandemic, investors are engaging their portfolio companies around the growing reputational, financial, and regulatory ...
Read more
6th Jan 2022
Zeist, 6 January 2022 – A group of over 65 leading institutional investors is calling on Covid-19 vaccine manufacturers to move quickly to increase the availability and deployment of vaccinations around the world. An Investor Statement has been...
Read more
16th Dec 2021
To highlight the critical role of bank lending in the climate crisis, a group of institutional investors coordinated by the Interfaith Center on Corporate Responsibility (ICCR) announced they have filed a slate of nine proposals at top U.S. banks...
Read more
16th Dec 2021
As investor frustration mounts, the number of shareholder proposals soars to 17 citing a host of ESG concerns considered a threat to the public interest and material to investments. NEW...
Read more
10th Dec 2021
Shareholders withdraw a proposal for the 2022 proxy as Tyson agrees to study how its policies and practices may discriminate against ...
Read more
1st Dec 2021
On World AIDS Day, investors caution the pharma industry’s business model contributes to de-facto apartheid as race and income become focal points in the global struggle to gain access to life-saving medicines.NEW...
Read more
2nd Nov 2021
Federal regulations designed to mitigate methane leaks and flaring from oil & gas operations seen as one of the fastest, most effective ways to combat climate change. NEW...
Read more
28th Oct 2021
Licensing agreement means COVID-19 therapeutic, molnupiravir, said to cut COVID-19 hospitalizations and death in high-risk patients in half, will be available for generic manufacture in 105 countries, dramatically increasing access and...
Read more

Pages

Sign Up for our eNewsletter

* indicates required